Reply to H. B et al

Anne Sophie Defachelles; Emilie Bogart; Michela Casanova; Johannes H.M. Merks; Gianni Bisogno; Giuseppina Calareso; Soledad Gallego Melcon; Susanne Andrea Gatz; Marie Cecile Le Deley; Kieran McHugh; Alicia Probst; Nathalie Rocourt; Rick R. Van Rijn; Veronique Minard-Colin; Julia C. Chisholm

doi:10.1200/JCO.21.02612

Reply to H. B et al

Anne Sophie Defachelles, Emilie Bogart, Michela Casanova, Johannes H.M. Merks, Gianni Bisogno, Giuseppina Calareso, Soledad Gallego Melcon, Susanne Andrea Gatz, Marie Cecile Le Deley, Kieran McHugh, Alicia Probst, Nathalie Rocourt, Rick R. Van Rijn, Veronique Minard-Colin, Julia C. Chisholm

Résultats de recherche: Contribution à un journal › Letter › Revue par des pairs

langue originale	Anglais
Pages (de - à)	1030-1031
Nombre de pages	2
journal	Journal of Clinical Oncology
Volume	40
Numéro de publication	9
Les DOIs	https://doi.org/10.1200/JCO.21.02612
état	Publié - 20 mars 2022

Accès au document

10.1200/JCO.21.02612

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

@article{ab6436cc7e5a4362a710a7983637927c,

title = "Reply to H. B et al",

author = "Defachelles, {Anne Sophie} and Emilie Bogart and Michela Casanova and Merks, {Johannes H.M.} and Gianni Bisogno and Giuseppina Calareso and Melcon, {Soledad Gallego} and Gatz, {Susanne Andrea} and {Le Deley}, {Marie Cecile} and Kieran McHugh and Alicia Probst and Nathalie Rocourt and {Van Rijn}, {Rick R.} and Veronique Minard-Colin and Chisholm, {Julia C.}",

note = "Funding Information: The VIT trial is an academic clinical trial funded through multiple national and international government agencies and cancer charities: Association Enfants et Sant{\'e}, Soci{\'e}t{\'e} Fran{\c c}aise de Lutte Contre les Cancers et les Leuc{\textquoteright}emies de l{\textquoteright}Enfant et de l{\textquoteright}Adolescent (SFCE), France; The French National Cancer Institute by a grant of PHRC-K14-073; Fondazione Regionale per la Ricerca Biomedica—Regione Lombardia, Italy; The Go4Children foundation and the Prinses Maxima Centrum Foundation, the Netherlands; and JHM Merks. This study represents independent research supported by the National Institute for Health Research (NIHR) Biomedical Research Center at The Royal Marsden NHS Foundation Trust and the Institute of Cancer Research, London (J.C.C.).",

year = "2022",

month = mar,

day = "20",

doi = "10.1200/JCO.21.02612",

language = "English",

volume = "40",

pages = "1030--1031",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

number = "9",

}

TY - JOUR

T1 - Reply to H. B et al

AU - Defachelles, Anne Sophie

AU - Bogart, Emilie

AU - Casanova, Michela

AU - Merks, Johannes H.M.

AU - Bisogno, Gianni

AU - Calareso, Giuseppina

AU - Melcon, Soledad Gallego

AU - Gatz, Susanne Andrea

AU - Le Deley, Marie Cecile

AU - McHugh, Kieran

AU - Probst, Alicia

AU - Rocourt, Nathalie

AU - Van Rijn, Rick R.

AU - Minard-Colin, Veronique

AU - Chisholm, Julia C.

N1 - Funding Information: The VIT trial is an academic clinical trial funded through multiple national and international government agencies and cancer charities: Association Enfants et Santé, Société Française de Lutte Contre les Cancers et les Leuc’emies de l’Enfant et de l’Adolescent (SFCE), France; The French National Cancer Institute by a grant of PHRC-K14-073; Fondazione Regionale per la Ricerca Biomedica—Regione Lombardia, Italy; The Go4Children foundation and the Prinses Maxima Centrum Foundation, the Netherlands; and JHM Merks. This study represents independent research supported by the National Institute for Health Research (NIHR) Biomedical Research Center at The Royal Marsden NHS Foundation Trust and the Institute of Cancer Research, London (J.C.C.).

PY - 2022/3/20

Y1 - 2022/3/20

UR - http://www.scopus.com/inward/record.url?scp=85126682105&partnerID=8YFLogxK

U2 - 10.1200/JCO.21.02612

DO - 10.1200/JCO.21.02612

M3 - Letter

C2 - 35130027

AN - SCOPUS:85126682105

SN - 0732-183X

VL - 40

SP - 1030

EP - 1031

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 9

ER -